首页 | 本学科首页   官方微博 | 高级检索  
     

骨髓增生异常综合征剪接体突变的研究进展
引用本文:黄林娜,刘鹏琴. 骨髓增生异常综合征剪接体突变的研究进展[J]. 中国肿瘤临床, 2017, 44(19): 1000-1004. DOI: 10.3969/j.issn.1000-8179.2017.19.144
作者姓名:黄林娜  刘鹏琴
作者单位:南华大学附属郴州第一人民医院检验科(湖南省郴州市423000)
摘    要:研究发现剪接体突变在骨髓增生异常综合征(myelodysplastic syndrome,MDS)疾病的发生发展中发挥重要作用,其突变基因包括SF3B1、U2AF1(U2AF35)、SRSF2、ZRSR2、PRPF40B、SF1、SF3A1和U2AF2等,突变基因(45%~85%)发生在mRNA剪接过程中的3'剪接位点,主要表现为杂合性错义突变。了解RNA剪接对MDS的靶向治疗及预后具有指导作用。本文就剪接体相关突变基因在MDS中的致病机制、靶向治疗及临床预后等进行综述。 

关 键 词:骨髓增生异常综合征   剪接体   基因突变   靶向治疗
收稿时间:2017-02-09

Research progress on spliceosome mutations in myelodysplastic syndromes
Linna HUANG,Pengqin LIU. Research progress on spliceosome mutations in myelodysplastic syndromes[J]. Chinese Journal of Clinical Oncology, 2017, 44(19): 1000-1004. DOI: 10.3969/j.issn.1000-8179.2017.19.144
Authors:Linna HUANG  Pengqin LIU
Affiliation:Department of Clinical Laboratory, Chenzhou First People's Hospital Affiliated to University of South China, Chenzhou 423000, China
Abstract:Spliceosomal dysfunction plays a major role in pathogenesis of myelodysplastic syndrome (MDS). Splicing factor somatic mutations, including SF3B1, U2AF1 (U2AF35), SRSF2, ZRSR2, PRPF40B, SF1, SF3A1, and U2AF2, comprise a common (45%–85%) class of mutated genes in MDS. These genes exist in a mutually exclusive manner at the 3'splice site of mRNA processing and are predomi-nantly heterozygous and missense. RNA splicing might have therapeutic and prognosis values in MDS. This review mainly describes the pathogenesis of common splicing factor gene mutations in MDS and discusses possible therapeutic implications, clinical analysis, and prognosis.
Keywords:myelodysplastic syndromes  spliceosome  mutations  targeted therapy
本文献已被 万方数据 等数据库收录!
点击此处可从《中国肿瘤临床》浏览原始摘要信息
点击此处可从《中国肿瘤临床》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号